Discovering and exploiting hidden pockets at protein protein interfaces
"Protein-protein interactions play critical roles in normal human physiology, as well as in numerous diseases such as cancers and neurodegenerative disorders. However, identifying small molecule drugs to block protein interactions...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PELE
P.E.L.E Protein Energy Landscape Exploration a la carte d...
1M€
Cerrado
BAP
A dynamical view of binding affinity
166K€
Cerrado
EBDD
Beyond structure integrated computational and experimental...
1M€
Cerrado
DRUGPROFILBIND
Chemogenomic profiling of drug protein binding by shape ent...
2M€
Cerrado
BES-2011-045634
DOCKING ENTRE PROTEINAS Y OTROS ASPECTOS: AVANCES EN LA DESC...
43K€
Cerrado
RYC-2011-07602
Exploring protein interactions and their modulation through...
184K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
"Protein-protein interactions play critical roles in normal human physiology, as well as in numerous diseases such as cancers and neurodegenerative disorders. However, identifying small molecule drugs to block protein interactions is a very difficult task. One of the major difficulties is that often the proteins involved are extremely flexible and readily change shape, which greatly complicates efforts to find small molecule ligands of matching shape. In this project, we aim to exploit protein flexibility to create new opportunities for drug discovery.
Interactions between a given pair of proteins commonly requires one or both partners to transiently form pockets that allow selective binding. Therefore, most protein interfaces likely possess many more binding pockets than those apparent in the static picture of a protein structure revealed by crystallographic experiments. We propose to identify these ""hidden"" pockets using computational methods. Thus, we will develop and validate molecular simulation methodologies to detect hidden pockets at protein interfaces and assess their small molecule ""druggability"" using docking calculations and binding site scoring functions. Such capacity would greatly strengthen the reliability of in silico drug design. We will perform virtual screens to find small molecule ligands binding to hidden pockets in medicinally important proteins such as FcgammaRIIA or PCNA. Finally, we will purchase or synthesize promising ligands and assay their activity against protein targets. These studies will allow us to test the utility of our computational approach in rational drug design.
The objectives of this research are part of a broader program we are currently developing and whose purpose is to provide a comprehensive set of computational/biophysical methods to allow the widespread targeting of seemingly ""undruggable"" protein families with small molecules, thereby expanding the scope of modern molecular medicine."